Article Details
Retrieved on: 2021-02-05 13:52:30
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
(NASDAQ: DNLI), a biopharmaceutical company developing a broad portfolio of product candidates engineered to cross the blood-brain barrier (BBB) ...
Article found on: www.globenewswire.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here